Drug
L-ornithine-L-aspartate
L-ornithine-L-aspartate is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_4
2
67%
Ph phase_2
1
33%
Phase Distribution
0
Early Stage
1
Mid Stage
2
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 4Post-market surveillance
2(66.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(2)
Other(1)
Detailed Status
Completed2
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 21 (33.3%)
Phase 42 (66.7%)
Trials by Status
unknown133%
completed267%
Recent Activity
0 active trials
Showing 3 of 3
completedphase_4
Efficacy of L-Ornithine L-Aspartate in Acute Hepatic Encephalopathy.
NCT01041755
completedphase_2
The Effectiveness of L-ornithine-L-aspartate (LOLA) on Plasma Ammonia in Cirrhotic Patients After TIPS
NCT01440829
unknownphase_4
Therapeutic Efficacy of Oral L-Ornithine-L-Aspartate on Minimal Encephalopathy
NCT00896831
Clinical Trials (3)
Showing 3 of 3 trials
NCT01041755Phase 4
Efficacy of L-Ornithine L-Aspartate in Acute Hepatic Encephalopathy.
NCT01440829Phase 2
The Effectiveness of L-ornithine-L-aspartate (LOLA) on Plasma Ammonia in Cirrhotic Patients After TIPS
NCT00896831Phase 4
Therapeutic Efficacy of Oral L-Ornithine-L-Aspartate on Minimal Encephalopathy
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3